IHSI’s Executive Committee has met for the second face-to-face meeting this year on 22-23 November 2023. We are proud to welcome Martin Lerner, MD and Department Director at the Norwegian Institute of Public Health, as the 5th member of IHSI’s Board of Directors (BOD). Dr. Lerner will be joining the IHSI BOD for a four-year […]
In a special meeting in Copenhagen on 16 November 2022, the IHSI Executive Committee (EXCO) unanimously re-appointed Prof. Diana Delnoij as Chair of the IHSI Board of Directors (BOD) and IHSI Executive Committee. During the same meeting, the EXCO also renewed the terms of all current serving BOD members, namely: Roisín Adams from the National […]
IHSI would like to cordially invite you to attend the 2022 Virtual IHSI Conference (Public) on Thursday 2 June from 17:00 to 18:00 CEST. The event will serve as IHSI’s first public event and we are very much looking forward to welcoming guests back together as the Joint Horizon Scanning Database gets ready to launch. […]
The system is based on the joined best practices of all IHSI memberstates.
A comprehensive global database tracking pharmaceutical developments from clinical trial phase I to market access approval.
Our specialised AI model utilizes LLM, NLP and machine learning, for data harvesting and curation, ensuring best-in-class data.
It is record based. Each record represents one indication of an individual pharmaceutical product; Each record has 152 unique data fields. Updated every 28 days.
Contact us
If you want to reach out to us, please leave a message and we will get in touch with you as soon as possible.